首页> 外文期刊>Internal medicine. >Community-acquired Chlamydia pneumoniae pneumonia in Japan: a prospective multicenter community-acquired pneumonia study.
【24h】

Community-acquired Chlamydia pneumoniae pneumonia in Japan: a prospective multicenter community-acquired pneumonia study.

机译:日本社区获得性肺炎衣原体肺炎:一项前瞻性多中心社区获得性肺炎研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate the clinical features of Chlamydia pneumoniae pneumonia in Japan and to evaluate the newly created Japanese community-acquired pneumonia (CAP) guidelines. PATIENTS AND METHODS: A multicenter CAP surveillance study was carried out in 20 hospitals between December 1999 and March 2000. The diagnosis of C. pneumoniae infection was based on isolation in cell culture, the polymerase chain reaction and serologic testing of antibodies by the microimmunofluorescence test. RESULTS: Among 232 CAP cases, C. pneumoniae was identified as the etiologic agent in 15 cases (6.5%). C. pneumoniae was the only pathogen identified in nine of these cases, while one or more additional etiological agents were found in the other six cases. Of the present and previously reported single agent C. pneumoniae pneumonia cases, about 50% were more than 60 years old and had underlying diseases. A relatively slow pulse rate in relation to fever was not seen in these patients. The mean WBC count of all patients was normal. No patient required respiratory support or admission to an intensive care unit and no deaths occurred among these patients. CONCLUSION: The clinical pictures of C. pneumoniae pneumonia as a single agent were mild to moderate and were remarkably different from those of cases of C. pneumoniae pneumonia concomitant with other bacteria. If the patient is less than 60 years old and some guideline headings are excluded, we think it would be possible to distinguish between C. pneumoniae and bacterial pneumonia.
机译:目的:调查日本的肺炎衣原体肺炎的临床特征,并评估新制定的日本社区获得性肺炎(CAP)指南。患者与方法:1999年12月至2000年3月,在20家医院进行了多中心CAP监测研究。肺炎衣原体感染的诊断基于细胞培养中的分离,聚合酶链反应和通过微免疫荧光试验对抗体进行血清学检测。结果:在232例CAP病例中,有15例(6.5%)被确定为肺炎衣原体的病因。肺炎衣原体是其中9例中唯一鉴定出的病原体,而其他6例中还发现了一种或多种其他病原体。在目前和以前报道的单药肺炎衣原体肺炎病例中,约有50%年龄超过60岁并患有基础疾病。在这些患者中未观察到与发烧有关的相对较慢的脉搏率。所有患者的平均白细胞计数均正常。没有患者需要呼吸支持或进入重症监护病房,这些患者中没有发生死亡。结论:肺炎衣原体肺炎作为单一药物的临床表现为轻度至中度,与其他细菌感染的肺炎衣原体肺炎的临床表现明显不同。如果患者小于60岁,并且排除了某些指导性标题,我们认为可以区分肺炎衣原体和细菌性肺炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号